FAMBROUGH DOUGLAS (Chief Executive Officer) purchased 13.1% of their position (5K shares) of DICERNA PHARMACEUTICALS INC on the open market
Open‑market purchase worth $110.5K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/10/2021ACC: 0001399529-21-000146
DirectorOfficer· Chief Executive Officer
Since Jan 2019
+5K
Net shares
Net buyer
$110.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$22.10
Trade value
$110.48K
% of position
13.1%
8/10/2021
38.16K→43.16K
Total
Net shares
+5K
Net value
$110.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2021 | P · Purchase | +5K | $22.10 | $110.48K | 13.1% | 38.16K | 43.16K |
| Total | +5K | $110.48K | ||||||
Derivative Transactions0
No derivative transactions reported